Table 1.
Control | SHR | SHR+Enalapril | |
---|---|---|---|
n | 9 | 8 | 6 |
LVDD, mm | 5.59 ± 0.32 | 6.44 ± 0.16 | 6.07 ± 0.11 |
STh, mm | 1.52 ± 0.03* | 1.85 ± 0.03* | 1.71 ± 0.02* |
LVPWTh, mm | 1.55 ± 0.02* | 1.92 ± 0.06* | 1.70 ± 0.03* |
ES, % | 60.76 ± 0.89 | 60.87 ± 0.46 | 61.39 ± 1.34 |
MVS, % | 30.60 ± 1.51 | 30.53 ± 0.96 | 30.66 ± 0.77 |
LVMI | |||
mg/g | 1.39 ± 0.09* | 2.61 ± 0.12* | 2.04 ± 0.05* |
mg/mm | 12.79 ± 1.05* | 21.43 ± 1.15* | 17.81 ± 0.39* |
Values are means ± SE; n, no. of rats. SHR, spontaneously hypertensive rats; LVDD, left ventricular diastolic diameter; STh, septum thickness; LVPWTh, left ventricular posterior wall thickness; ES, endocardial shortening; MVS, midwall ventricular shortening; LVMI, left ventricular mass index.
P < 0.05 vs. all others groups.